ASX:IME ImExHS (IME) Stock Price, News & Analysis → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free IME Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.09 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ImExHS alerts: Email Address Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! About ImExHSImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.Read More Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! IME Stock News HeadlinesMarch 4, 2024 | finance.yahoo.comImExHS Full Year 2023 Earnings: AU$0.10 loss per share (vs AU$0.085 loss in FY 2022)December 22, 2023 | msn.comCRITERION: Missed the Pro Medicus boat? These cheaper alternatives scan wellApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!November 29, 2023 | tmcnet.comTeleradiology Market to Reach $46.7 Billion, Globally, by 2032 at 18.1% CAGR: Allied Market ResearchSeptember 5, 2023 | finance.yahoo.comImExHS First Half 2023 Earnings: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)July 15, 2023 | finance.yahoo.comInsider Stock Buying Reaches AU$1.1m On ImExHSJuly 4, 2023 | uk.finance.yahoo.comRadiology Services Global Market Report 2023April 17, 2023 | finance.yahoo.comImExHS Limited (ASX:IME) Could Be Riskier Than It LooksApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!February 4, 2023 | yahoo.comBullish insiders at ImExHS Limited (ASX:IME) loaded up on AU$1.1m of stock earlier this yearJuly 31, 2022 | afr.comCelsius Resources, Change Financial, Mighty Kingdom in placementsMay 4, 2022 | finance.yahoo.comHealth Check: How Prudently Does ImExHS (ASX:IME) Use Debt?March 19, 2022 | finance.yahoo.comMultiple insiders bought ImExHS Limited (ASX:IME) stock earlier this year, a positive sign for shareholdersJanuary 19, 2022 | finance.yahoo.comBreakeven Is Near for ImExHS Limited (ASX:IME)October 9, 2021 | uk.finance.yahoo.comAdele credits gruelling gym sessions with helping her to combat anxietyOctober 9, 2021 | nz.finance.yahoo.comINDUS Announces Fiscal 2021 Third Quarter Earnings CallOctober 9, 2021 | nz.finance.yahoo.comAndy Murray Says He's in Hot Water 'at Home' After Wedding Ring Was Stolen While Tied to His ShoesOctober 7, 2021 | finance.yahoo.comDouglas Lingard Is The Independent Non-Executive Director of ImExHS Limited (ASX:IME) And They Just Picked Up 6.6% More SharesAugust 12, 2021 | finance.yahoo.comMarket Sentiment Around Loss-Making ImExHS Limited (ASX:IME)July 25, 2021 | msn.comASX health stocks: 4D Medical leads after ramping up its game in the USSee More Headlines Receive IME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:IME CUSIPN/A CIKN/A Webimexhs.com Phone57 1 316 4890FaxN/AEmployees400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,190,000.00 Net Margins-21.08% Pretax MarginN/A Return on Equity-26.30% Return on Assets-6.84% Debt Debt-to-Equity Ratio8.09 Current Ratio1.40 Quick Ratio1.24 Sales & Book Value Annual Sales$19.89 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.50 Book ValueA$0.38 per share Price / BookN/AMiscellaneous Outstanding Shares45,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.28 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. German ArangoCo-Founder, CEO, MD & DirectorMs. Reena Minhas ACACFO & Company SecretaryDr. Jorge H-Marin MunozCo-Founder & Chief Medical OfficerMr. Andres VanegasCo-Founder & Strategic Accounts ManagerMr. Alexander SanzCo-Founder & CTOMr. Orlando JovenChief Operating OfficerMr. Juan Sebastian BonnetHead of SalesMr. Benjamin BrinquisHead of GrowthMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersDamian BanksSold 47,508 sharesTotal: $28,504.80 ($0.60/share)Damian BanksSold 23,754 sharesTotal: $10,000.43 ($0.42/share)Carlos PalacioSold 403,066 sharesTotal: $255,946.91 ($0.64/share)Douglas (Doug) FlynnSold 286,378 sharesTotal: $177,554.36 ($0.62/share)Douglas (Doug) FlynnBought 119,540 shares on 9/6/2023Total: $77,103.30 ($0.65/share) IME Stock Analysis - Frequently Asked Questions How were ImExHS's earnings last quarter? ImExHS Limited (ASX:IME) issued its earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. ImExHS had a negative net margin of 21.08% and a negative trailing twelve-month return on equity of 26.30%. This page (ASX:IME) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImExHS Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
